Regulation of cancer cell ferroptosis by PTRF/Cavin-1
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Reducing PTRF protein sensitizes ovarian cancer cells to ferroptosis, a cell death pathway. This finding offers a novel therapeutic strategy for improving ovarian cancer treatment outcomes.
Area Of Science
- Oncology
- Cell Biology
- Biochemistry
Background
- Ovarian cancer has a high recurrence rate, necessitating novel therapeutic strategies.
- Ferroptosis, an iron-dependent cell death, is a potential therapeutic target in cancer.
- PTRF (Cavin-1) is a protein associated with cell membrane structures and cellular processes.
Purpose Of The Study
- To investigate the role of PTRF in ferroptosis of ovarian cancer cells.
- To explore PTRF as a potential therapeutic target for ovarian cancer.
Main Methods
- Ovarian cancer cell lines (HEY, SKOV3) were used.
- PTRF was knocked down using siRNA.
- Ferroptosis was induced using Erastin.
Main Results
- Knockdown of PTRF sensitized ovarian cancer cells to Erastin-induced ferroptosis.
- Reduced PTRF expression may alter cell membrane stability and tension.
- This alteration potentially impacts ferroptosis-related signaling pathways.
Conclusions
- PTRF plays a role in regulating ferroptosis sensitivity in ovarian cancer.
- Targeting PTRF could be a novel strategy for ovarian cancer therapy.
- Further research into PTRF's mechanism in ferroptosis is warranted.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...